Immature myeloid cells and cancer-associated immune suppression

Cancer Immunology, Immunotherapy

Volumn 51, Issue 6, 2002, Pages 293-298

  Kusmartsev, Sergei ^a   Gabrilovich, Dmitry I ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; Immature myeloid cell; Immune suppression; Immune tolerance; T cell response

Indexed keywords

ANIMAL MODEL; BONE MARROW CELL; CANCER; CELL COUNT; CELL FUNCTION; CELL HETEROGENEITY; CELL POPULATION; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE MODEL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGIC SURVEILLANCE; INTERFERON TYPE II; LYMPHOKINES; MACROPHAGE-1 ANTIGEN; MICE; MODELS, IMMUNOLOGICAL; MYELOID CELLS; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036301973     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0280-8     Document Type: Review

References (57)

1. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
2. Clinical significance of defective dendritic cell differentiation in cancer
3. Increased production of immature myeloid cells in cancer patients as a mechanism of immunosuppression in cancer
4. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex
5. + T cell proliferation via an interferon-gamma- and nitric oxide-dependent mechanism
6. The role of interferon-gamma in the regulation of antiproliferative activity of non-adherent bone marrow cells
7. + cells
8. + T cell response by dysregulating antigen-presenting cell maturation
9. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells
10. Human dendritic cells response to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10
11. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma
12. +, T cells from mammary tumor-bearing mice have a down-regulated production of IFN-gamma; role of phosphatidylserine
13. Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells
14. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
15. Vascular endothelial growth factor effects on nuclear factor-kappa B activation in hematopoietic progenitor cells
16. IL-10 does not affect phagocytosis of particulate antigens by bone-marrow derived dendritic cells but does impair antigen presentation
17. The biology of vascular endothelial growth factor
18. Where have all the T cells gone? Mechanisms of immune evasion by tumors
19. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor
20. + cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells
21. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
22. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
23. Mechanism of immune dysfunction in cancer mediated by immature Gr-1(+) myeloid cells
24. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
25. Granulocytes, macrophages and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow
26. Mechanisms of tumor-induced immunosuppression: Evidence for contact-dependent T cell suppression by monocytes
27. Dendritic cells as a tool to induce anergic and regulatory T cells
28. + myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation
29. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1
30. Enhanced autoimmune arthritis in IFN-γ receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1 myeloid cells
31. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: Role of interleukin-6 and macrophage-colony-stimulating factor
32. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
33. 2-dependent and independent immune suppressor cells by tumor-derived GM-CSF and M-CSF
34. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappaB activation in hemopoietic progenitor cells
35. Therapeutic vaccination for cancer
36. Cyclophosphamide induces the development of early myeloid cells suppressing tumor growth by a nitric oxide-dependent mechanism
37. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes
38. Induction of antitumor immunity using bone marrow-generated dendritic cells
39. Ehrlich tumor stimulates extramedullar hematopoiesis in mice without secreting identifiable colony-stimulating factors and without engagement of host T cells
40. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells im gastric carcinoma tissue
41. Resection of solid tumors reverses T cell defects and restores protective immunity
42. Dendritic cells as adjuvants for immune-mediated resistance to tumors
43. IFN-gamma and lymphocytes prevent primary tumor development and shape tumor immunogenicity
44. T-cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function
45. Neuroblastoma derived gangliosides inhibit dendritic cell generation and function
46. Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
47. Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice
48. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T-cells and induces regression of some metastases in advanced stage IV melanoma
49. Clinical significance of the determination of angiogenic factors
50. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells
51. Splenic macrophages from tumor-bearing mice co-expressing Mac-1 and Mac-2 antigens exert immunoregulatory functions via two distinct mechanisms
52. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses
53. Signaling defects in T lymphocytes of patients with malignancy
54. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors
55. Antibodies to colonystimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells
56. Human squamos cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cells
57. Changes in macrophage populations: Phenotypic di2erences between normal and tumor-bearing host macrophages